UriFind®️, is based on the high-throughput sequencing data of Chinese bladder cancer patient samples, combined with the TCGA database, to screen out bladder cancer-specific methylation sites, and statistically analyze thousands of cases The test results of urine samples of clinical patients in the United States have constructed a bladder cancer diagnosis model. UriFind®️can accurately detect bladder cancer by detecting urine samples of the subject, effectively overcoming the limitations of conventional diagnostic methods and improving the diagnostic level of bladder cancer.
Bladder Cancer, Urothelial Cancer